Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Galapagos

Explore full profile

Clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines

Mechelen, BelgiumFounded 1999Biotech & Life Sciences
Revenue $1.22B Latest reported FY
EBITDA $665M Latest reported FY

At a glance

Founded
1999
Headquarters
Mechelen, Belgium
Listing
IPO 2015
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Thuja Capital

Series B and later1 investor entered at this stage

  • Gilde Healthcare

Talent

Book a demo to see the people
Employees mapped 635 incl. 9 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 21 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

5 of 7 startups shown

Former Galapagos employees who went on to found companies, sorted by Dealroom signal score.

myTomorrowsEst. 2012
Ronald BrusNetherlands
Signal score90
Coultreon BiopharmaEst. 2025
PRPierre RaboissonBelgium
Signal score87
Scienta LabEst. 2021
Camille BougetFrance
Signal score73
Leyden LabsEst. 2020
Dinko ValerioNetherlands
Signal score69
eChemiclesEst. 2017
Richard JonesHungary
Signal score67
2 more alumni-founded companies in this previewBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
🇧🇪 Belgium · Mechelen HQ
Book a demo for the full country breakdown
Web traffic by country
11K monthly visits
across markets
🇧🇪 Belgium28.2%
🇺🇸 United States23.6%
🇬🇧 United Kingdom17.3%
🇳🇱 Netherlands12.7%
🇮🇳 India12.7%
Top 5 markets shown

Patents

Estimated portfolio value
$225M

107 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Galapagos was the backer or acquirer, 2013–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

7 deals across Galapagos's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Galapagos deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Galapagos's portfolio, mapped.

        Stage
        Period
        7 of 7 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Galapagos on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Galapagos on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles